Emerging #cancer therapies such as #immunotherapy, targeted therapy, and cell therapy have advanced rapidly in recent years. Among these, antibody-drug conjugates (#ADC), sometimes referred to as a “biological missile”, can specifically attack cancer cells without causing harm to normal cell tissues. This approach considerably increased anti-tumor specificity resulting in reduced toxic side effects. syngeneic mouse models ADCs are typically made up of fully humanized monoclonal antibodies, cytotoxic agent, and linkers that combine the properties of a targeted and chemotherapeutic agent to deliver precision cancer therapy. ADC was first proposed by Paul Ehrlich,…
Read MoreSunday, September 15, 2024
Recent posts
